Lethal asphyxiating juvenile laryngeal papillomatosis. A case report with human papillomavirus in situ hybridization

K Sperry1

  • 1Fulton County Medical Examiner's Office, Atlanta, GA 30303.

Insights

Juvenile laryngeal papillomatosis caused by HPV types 6/11 can be fatal. This case highlights a child

Area of Science:

  • Medical Pathology
  • Virology
  • Pediatric Medicine

Background:

  • Juvenile laryngeal papillomatosis is a rare, chronic condition caused by human papillomavirus (HPV) types 6/11, primarily affecting children.
  • Recurrent papillomas necessitate repeated surgeries to maintain airway patency and can, rarely, lead to sudden death.

Observation:

  • A case of a 22-month-old girl with laryngeal and pharyngeal papillomata who died unexpectedly in her sleep.
  • Autopsy revealed extensive papillomata obstructing the laryngeal lumen.

Findings:

  • In situ hybridization confirmed HPV types 6/11 positivity in autopsy tissues.
  • This is the first reported instance of in situ hybridization on autopsy tissue from a sudden death due to upper airway obstructive papillomatosis.

Implications:

  • This case underscores the potential lethality of juvenile laryngeal papillomatosis, even in previously managed cases.
  • Highlights the utility of in situ hybridization in post-mortem analysis of HPV-related deaths.
  • Emphasizes the critical need for vigilant management of pediatric airway papillomas.

Related Concept Videos

In-situ Hybridization02:31

In-situ Hybridization

In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...